JiYu’s Push into Longevity Skincare: How an American-Founded K-Beauty Brand Is Targeting $100M by 2026

Table of Contents

1. Key Highlights
2. Introduction
3. A hybrid identity: American founders, Korean formulation, global ambitions
4. Defining “longevity skincare”: beyond anti‑aging to cellular maintenance
5. Ingredients and delivery: how Korean formulation approaches cellular health
6. Manufacturing credibility: why Seoul-based ODM relationships matter
7. Distribution and growth: product-led expansion on digital platforms
8. Funding, evidence, and the business of making longevity claims
9. Competitive landscape: where JiYu fits among K‑beauty and science brands
10. Consumer considerations: safety, expectations, and regimen integration
11. Industry implications: how JiYu’s approach could shape beauty’s next phase
12. Challenges and potential pitfalls for longevity-first brands
13. Looking ahead: JiYu’s near-term roadmap and what to watch
14. FAQ

Key Highlights

• JiYu, a K‑beauty brand formulated and manufactured in South Korea, is expanding into longevity-focused skincare and projects $100 million in revenue by 2026, driven by product performance and creator-led distribution.
• The brand combines Korean formulation precision, advanced delivery systems (for ingredients like NAD+), and a proprietary K8‑Rejuvenate™ complex to target cellular skin health; manufacturing relationships in Seoul and international quality certifications underpin its strategy.

Introduction

A new chapter in beauty has begun where cellular science and Korean formulation meet at scale. JiYu, founded by American entrepreneurs and produced in South Korea, is positioning itself as more than a K‑beauty label: it is building a product portfolio aimed at supporting skin at the cellular level, not only addressing surface concerns. The brand’s stated target—$100 million in revenue by 2026—reflects rapid consumer adoption and a business model that leans on product efficacy, creator-driven storytelling, and direct-to-consumer channels. JiYu’s expansion into longevity skincare signals how Western consumer demand for preventative, science-backed beauty is aligning with a manufacturing ecosystem in Korea known for pioneering actives and delivery systems.

The following analysis examines what JiYu is doing differently, why its Korea‑first approach matters, how longevity science is shaping skincare formulations, and what the brand’s rise implies for the broader industry. Perspectives from JiYu’s leadership combine with industry context to explain how formulation, manufacturing, distribution, and evidence-based claims are converging as beauty companies compete for long-term skin outcomes.

A hybrid identity: American founders, Korean formulation, global ambitions

JiYu’s organizational model intentionally straddles borders. Founded by American female entrepreneurs with offices in Miami and Austin, the company locates product development and manufacturing in Gangnam, Seoul—an area synonymous with South Korea’s cosmetics innovation. That hybrid identity delivers two complementary advantages.

First, the brand benefits from access to South Korea’s specialized cosmetics supply chain. Korean original development manufacturers (ODMs) and contract manufacturers have deep expertise in novel actives, microencapsulation, and other delivery technologies. These relationships grant JiYu earlier access to ingredients and formulations that may take longer to reach foreign brands. JiYu emphasizes that its products come directly from Korean facilities with no domestic reformulation or third‑party repackaging, ensuring formulation fidelity between research bench and consumer bathroom.

Second, an American founding team provides market and distribution know‑how tailored to U.S. consumer behavior. JiYu’s offices in Miami and Austin manage e‑commerce operations, creator partnerships, and consumer insights—activities that differ from traditional Korean B2B OEM relationships. This allows the brand to translate Korean formulation strengths into product positioning that resonates with Western audiences interested in preventive health and measurable efficacy.

The combination has practical consequences. Products carrying both Korean formulation credentials and an American‑market orientation can move quickly across platforms—TikTok Shop, Amazon, and direct Shopify storefronts—while keeping manufacturing centralized in Seoul. The model is not unique, but it is strategic: global brands that split development across geographies can dilute formulation intent; JiYu preserves its Seoul-developed formulas and pairs them with U.S.-facing marketing and distribution.

Defining “longevity skincare”: beyond anti‑aging to cellular maintenance

The term “longevity skincare” summarizes a shift in emphasis from concealing visible signs of aging to supporting the biological processes that determine how skin functions over time. JiYu uses that language deliberately. The company argues that healthy skin requires support at the level of cells, mitochondria, and the extracellular environment—areas that traditional topical cosmetics have addressed only partially.

Key differences between classic anti‑aging and longevity approaches:

• Anti‑aging historically targets visible endpoints—wrinkles, loss of elasticity, uneven tone—often through exfoliation, collagen stimulation, and temporal plumping.
• Longevity skincare seeks to optimize processes behind those endpoints: cellular energy metabolism, DNA repair pathways, barrier integrity, and chronic low‑grade inflammation that accelerates degeneration.

JiYu’s product strategy reflects this orientation. The inclusion of NAD+—a coenzyme linked to cellular energy and repair—is emblematic. NAD+ has emerged across scientific literature and consumer health circles for its role in sirtuin activation and mitochondrial function. Topical formulations that incorporate NAD+ or its precursors aim to supply substrates or stimulate pathways that support cellular repair in situ. Achieving relevant biological activity through topical delivery requires not only the right active but also an effective delivery system to improve skin penetration and bioavailability; Korean delivery technologies are often cited as advanced in this respect.

Beyond NAD+, JiYu’s K8‑Rejuvenate™ complex blends actives associated with barrier repair, anti‑oxidation, pigmentation control, and collagen support: Snail Mucin, Centella Asiatica, Niacinamide, Alpha‑Arbutin, and a multi‑peptide complex. The approach treats products as systems—multiple ingredients working together over time—salient for consumers who favor cumulative benefits over single‑ingredient “hero” solutions.

A practical example: a peptide-rich serum may support collagen signaling, while Niacinamide strengthens barrier function and reduces transepidermal water loss. When combined with a delivery system that increases cellular uptake, the formulation’s net effect can extend from symptomatic smoothing to measurable improvements in resilience and repair. JiYu’s positioning asserts that Korean formulation practices—which emphasize layered regimens and active synergy—are well matched to this systems-based longevity thinking.

Ingredients and delivery: how Korean formulation approaches cellular health

Korean skincare gained global attention for multi‑step regimens and meticulous attention to texture, absorption, and ingredient combinations. The next iteration emphasizes not just layers but biochemical strategy: which molecules can influence cellular pathways and how to deliver them into relevant skin compartments.

NAD+ and its role NAD+ (nicotinamide adenine dinucleotide) is central to energy metabolism and DNA repair. As cells age, NAD+ levels decline, corresponding with reduced repair capacity and mitochondrial function. In topical applications, the challenge lies in maintaining molecular stability and ensuring penetration to the epidermal and dermal cells that can benefit from increased coenzyme availability. Formulators may use stabilized precursors or encapsulated systems to protect NAD+ from degradation and enhance delivery.

Peptides and signal modulation Peptides act as physiologically mimetic signals—short amino‑acid sequences designed to stimulate collagen production, modulate inflammation, or support barrier proteins. Multi‑peptide complexes allow brands to target several pathways in parallel: fibroblast activity, glycosaminoglycan synthesis, and extracellular matrix maintenance. Combining peptides with antioxidants and barrier modulators reduces the inflammatory milieu that accelerates structural decline.

Snail mucin and botanical actives Snail mucin contains glycoproteins and growth‑factor‑like molecules associated with hydration and reparative processes. Centella Asiatica is valued for its asiaticoside and madecassoside components, which are linked to barrier repair and collagen modulation. These traditional and botanical actives complement high‑tech molecules by managing moisture, calming irritation, and supporting the physical structures that permit cellular repair to proceed efficiently.

Delivery systems: bioavailability without compromise A formulation’s active roster matters less without effective delivery. Korean manufacturers have invested heavily in microencapsulation, liposomal technologies, nanoemulsions, and complex emulsifiers that increase penetration without causing irritation. Encapsulation can protect labile molecules like NAD+ from oxidation and enable time‑released delivery. Liposomes mimic cell membranes, assisting transport of both hydrophilic and lipophilic actives. Such systems become crucial when attempting to create topical products that influence intracellular pathways rather than surface chemistry alone.

JiYu emphasizes that its products use advanced Korean delivery systems to improve bioavailability, indicating an intentional prioritization of both active selection and technological scaffolding. For consumers, that translates into formulations designed for measurable, long‑term benefits rather than immediate cosmetic effects only.

Manufacturing credibility: why Seoul-based ODM relationships matter

JiYu’s choice to formulate and manufacture exclusively in South Korea is strategic. South Korea’s cosmetics manufacturing sector includes ODMs and contract manufacturers with decades of refinement in product development, regulatory navigation, and supply chain partnerships. For brands seeking to incorporate cutting‑edge actives, direct relationships with established Korean manufacturers yield several concrete advantages.

Access to specialized actives and proprietary technologies Many advanced ingredients and novel delivery systems originate with Korean R&D teams. ODMs often have exclusive or early access to proprietary ingredient blends, patented encapsulation methods, and co‑development pipelines that are difficult to replicate outside Korea. Maintaining those relationships allows JiYu to source certain formulations and technologies faster than competitors reliant on broader global suppliers.

Streamlined formulation-to-production pipeline When product development and manufacturing coexist within the same ecosystem, iteration cycles accelerate. In-house pilot batches, rapid stability testing, and quick adjustments to ingredient ratios reduce time to market. JiYu signals that its Seoul team is expanding, enabling closer coordination between formulation scientists and production engineers—important for a brand pivoting toward clinical evidence generation.

International quality certifications JiYu reports production under certifications including CGMP (Current Good Manufacturing Practice), ISO 9001 (quality management), ISO 14001 (environmental management), and ISO 22716 (cosmetics GMP). These standards indicate robust manufacturing governance: standardized procedures, traceability, environmental controls, and product consistency. For consumers and retailers, such certifications reduce risk and support claims of quality and safety.

No domestic reformulation JiYu imports products directly from Korean facilities to U.S. consumers without domestic reformulation or co‑packing. This preserves the integrity of Seoul‑authored formulations and avoids potential variability introduced by repackaging or reformulation in other jurisdictions. It also means that ingredient lists and efficacy data reflect the exact products developed in Korea, which can matter both for regulatory compliance and consumer trust.

Real-world parallel: luxury and mass brands alike have leaned on Korean ODMs when seeking to innovate quickly. High‑profile collaborations and private‑label initiatives demonstrate how manufacturers in Korea can accelerate product innovation and provide a pathway for international brands to introduce technologies that might otherwise remain regionally constrained.

Distribution and growth: product-led expansion on digital platforms

JiYu’s rise is notable for being product-first and creator-driven rather than dependent on large ad budgets or traditional retail placements. That distribution strategy aligns with contemporary shifts in consumer discovery and purchase behavior.

Creator-led content and social proof Social platforms—particularly short‑form video and creator content—amplify authentic user experiences and accelerate trial. JiYu credits its growth to creator content and word of mouth, suggesting product efficacy that converts first‑time buyers into repeat customers. In an environment where many consumers rely on reviews, tutorials, and unpacking videos, strong performance can generate earned visibility that scales faster than paid campaigns.

Multi-channel e‑commerce presence JiYu reports meaningful revenue from TikTok Shop, Amazon, and its Shopify storefront. Each channel offers distinct advantages:

• TikTok Shop enables discovery through viral moments and creator recommendations, often driving immediate conversion.
• Amazon provides discoverability for shoppers conducting transactional searches and benefits from fulfillment and review systems.
• A brand’s own Shopify store supports deeper brand storytelling, subscriber retention (email and SMS), and higher lifetime value through controlled promotions.

A diversified presence reduces dependence on any single platform and captures customers at multiple points in the purchasing funnel. Brands that succeed across these channels typically blend engaging content, consistent fulfillment, and strong customer service to convert trial into loyalty.

Retail and South Korea market entry JiYu plans retail distribution and direct entry into the South Korean market alongside new product launches in 2026. Retail placements can broaden reach and strengthen brand credibility in categories where in‑person sampling still matters. Entering South Korea—a market with discerning consumers and abundant local options—demands strong localized marketing and competitive differentiation. Nevertheless, JiYu’s Seoul production base and relationships within the Korean supply chain may ease that transition.

Practical example: Glossier’s early trajectory shows how product‑driven communities can create demand that translates to retail interest; similarly, JiYu’s creator momentum could catalyze wholesale partnerships when paired with consistent product performance and supply stability.

Funding, evidence, and the business of making longevity claims

JiYu recently completed a $6.5 million capital raise and has allocated a portion of that funding to independent clinical research. That decision acknowledges a crucial reality: longevity framing demands more than marketing—it requires empirical evidence.

Why clinical research matters Consumers and regulators increasingly expect claims—particularly those implying biological modulation—to be supported by rigorous data. Clinical studies can document outcomes such as improvement in skin barrier function, reduction in transepidermal water loss, or changes in measured markers of repair. Independent studies, whether randomized controlled trials or well‑designed cohort studies, increase credibility among dermatologists, retailers, and discerning consumers.

Clinical evidence also shapes messaging. Brands with robust data can move from aspirational language to precise benefits—percentage improvements, validated endpoints, and duration of effect—without risking overstatement. This is particularly relevant for longevity positioning, which can otherwise veer into speculative territory.

Investor perspective and growth trajectory Projecting $100 million in revenue by 2026 requires scaling product lines, channel expansion, and significant customer retention. JiYu’s expectation relies on a combination of continued triple‑digit year‑over‑year growth, five new product launches slated for 2026, and expansion into retail and the Korean domestic market. For investors, these are compound bets: that product efficacy sustains word‑of‑mouth growth, that supply chain scale can meet demand while maintaining quality, and that clinical research will amplify trust among new consumer segments.

Risk mitigation strategies

• Manufacturing certifications and direct imports from Korea reduce product quality risk.
• Diversified channel strategy lowers exposure to platform-specific policy changes.
• Research investment aims to convert a formulation-led narrative into evidence‑based claims that resonate with professionals and cautious buyers.

Real-world contrast: brands that scaled quickly without sufficient supply or evidence sometimes face backlash (stockouts, inconsistent product quality, or regulatory scrutiny). JiYu’s approach of pairing manufacturing governance with clinical investment is designed to avoid those pitfalls as it aims for aggressive growth.

Competitive landscape: where JiYu fits among K‑beauty and science brands

JiYu occupies an intersection of categories: K‑beauty heritage, science‑forward formulation, D2C and social commerce distribution, and longevity framing. Understanding its competitive context clarifies both its differentiators and the challenges ahead.

K‑beauty incumbents vs. science brands Established Korean brands and conglomerates have long excelled at consumer-facing innovation—textures, essences, and regimen culture. Global science brands emphasize clinical backing and dermatologist endorsement. JiYu blends both: Korean technologies support formulation work while research investments aim to bridge the trust gap typical for newer entrants claiming physiological outcomes.

Direct competitors may include:

• Korean brands seeking global expansion and incorporating high‑tech actives.
• Western science brands adding Korean delivery systems to their arsenal.
• Indie D2C brands that grow through creator ecosystems and leverage targeted actives like peptides, retinoids, and antioxidants.

What distinguishes JiYu

• A Korea‑first formulation and manufacturing stance that preserves product integrity.
• A systems-based approach (K8‑Rejuvenate™) that emphasizes ingredient synergy rather than single‑hero claims.
• Early public commitment to clinical research to support longevity positioning.
• Sales momentum driven by creators and repeat customers rather than top-down advertising.

Potential challenges

• The longevity nomenclature is still being defined in consumer minds; translating cellular concepts into accessible, credible messaging requires care.
• Competing on claims without robust clinical backup could invite regulatory attention or consumer skepticism.
• International expansion, particularly into South Korea, invites local competition that operates with native market knowledge and brand loyalty.

Consumer considerations: safety, expectations, and regimen integration

For consumers deciding whether to adopt longevity skincare, practical considerations matter more than aspirational language. JiYu’s emphasis on formulations crafted in Korea and manufactured under international standards addresses safety and consistency. Yet consumers will judge the brand by outcomes, tolerability, and how new products fit into existing routines.

Safety and tolerability High‑potency actives and delivery systems can increase efficacy but also the risk of irritation, particularly when layered with other active treatments. Consumers should:

• Patch‑test new products.
• Introduce actives gradually.
• Coordinate with professionals when combining potent actives like retinoids, acids, or prescription agents.

The role of multi‑product systems JiYu’s systems approach implies regimen thinking: complementary products designed for morning and evening routines that deliver cumulative benefits over time. Consumers interested in longevity results should prioritize consistency and adherence; short‑term snapshots can misrepresent cumulative improvements that accrue over weeks or months.

Transparency and ingredient communication Clear labeling, accessible explanations of actives, and educational content help consumers set realistic expectations. Brands that provide clinical endpoints, usage guides, and contraindications reduce misuse and increase long‑term satisfaction.

Cost and value Efficacy frequently determines perceived value. A product with clear, measurable benefits and strong tolerability will retain customers even at premium price points. For brands like JiYu projecting significant growth, maintaining consistent quality and value perception will be essential to sustaining repeat purchase and favorable word‑of‑mouth.

Industry implications: how JiYu’s approach could shape beauty’s next phase

Several industry-wide trends intersect in JiYu’s narrative: the maturation of K‑beauty beyond texture and ritual; demand for evidence as consumers extend preventive health thinking into beauty; and the power of creator ecosystems to accelerate adoption. If JiYu’s model proves replicable, expect several downstream effects.

Greater emphasis on clinical validation As brands adopt longevity language, retailers and consumers will demand more robust substantiation. This could spawn an increase in third‑party studies, dermatologist partnerships, and standardized methodologies for measuring "cellular outcomes" in topical applications.

Consolidation of manufacturing influence Leading Korean ODMs and manufacturers may gain heightened strategic importance as Western brands seek advanced actives and delivery systems. Partnerships or equity plays between brands and manufacturers could become more common to secure proprietary access.

Elevated consumer sophistication As brands educate buyers about cellular pathways, consumers will seek clarity on what topical products can and cannot do. This could create an opportunity for brands that effectively translate science into actionable skincare plans, supported by evidence and professional endorsements.

Blurring of wellness and beauty Longevity framing further erodes the boundary between skincare and broader preventative health. Brands that align topical interventions with lifestyle guidance—sleep, nutrition, photoprotection—may gain credibility by offering holistic regimens that genuinely support long-term skin health.

Challenges and potential pitfalls for longevity-first brands

Ambition brings scrutiny. Brands that claim to impact cellular pathways must navigate a landscape of regulatory standards, scientific skepticism, and consumer expectations.

Regulatory nuance Different jurisdictions interpret claims about cellular modulation, repair, or longevity differently. Misaligned messaging can trigger regulatory reviews or force rewording of marketing materials. Brands need legal and regulatory expertise to ensure that efficacy claims conform to local advertising law and cosmetics regulation.

Scientific complexity Translating bench science into topical outcomes is nontrivial. Not every molecule that shows promise in vitro translates into clinical benefit when applied topically. Even when improvements occur, quantifying and attributing those outcomes to a single product requires rigorous trial design and analytic care.

Supply chain resilience Scaling production while maintaining quality requires foresight: securing ingredient supply, ensuring batch consistency, and avoiding stockouts that damage brand reputation. Reliance on specific ODMs or ingredients can be an asset and a risk if demand outstrips capacity.

Consumer education Longevity is a concept that requires clear communication to avoid overpromising. Brands must balance aspirational language with grounded, evidence-based expectations to build durable trust.

Looking ahead: JiYu’s near-term roadmap and what to watch

JiYu has signaled several tactical priorities that will determine how successfully it executes its vision.

Product launches Five new products planned for 2026 will test the brand’s ability to diversify offerings while retaining the core longevity promise. Product performance and reviews from early adopters will shape retail interest and expansion opportunities.

Clinical research outcomes Results from independent studies funded by JiYu could become decision points for dermatologists, retailers, and skeptical consumers. Positive, peer-reviewed outcomes would strengthen the brand’s position; ambiguous results would demand careful messaging.

Retail expansion and South Korea entry Securing retail distribution, particularly with established beauty chains and department stores, would broaden customer acquisition channels. Entering South Korea introduces a proof point: will a Korea‑manufactured brand find a receptive home audience, or will it face stiff competition from native incumbents?

Scaling creator partnerships strategically Maintaining authenticity while scaling creator-led marketing is a balancing act. JiYu will need to cultivate long-term creator relationships and invest in community management to keep product storytelling credible and conversion-effective.

Financial trajectory Hitting a $100 million revenue target by 2026 requires not only initial momentum but sustained customer lifetime value and healthy unit economics. Monitoring retention, average order value, and acquisition cost will reveal whether the brand’s growth is sustainable or reliant on transient virality.

FAQ

Q: What is longevity skincare and how is it different from anti‑aging products? A: Longevity skincare focuses on supporting the biological processes that maintain skin health over time—cellular energy, DNA repair, barrier integrity—whereas traditional anti‑aging often targets visible signs like wrinkles and pigmentation. Longevity formulations prioritize actives and delivery systems that influence cellular pathways, aiming for cumulative benefits.

Q: Is JiYu a Korean brand? A: JiYu is an American‑founded brand that formulates and manufactures its products in South Korea. The company operates offices in the U.S. (Miami and Austin) and in Seoul’s Gangnam district, maintaining production in Korean facilities with direct import to consumers.

Q: What ingredients does JiYu use for longevity benefits? A: JiYu highlights ingredients such as NAD+, Snail Mucin, Centella Asiatica, Niacinamide, Alpha‑Arbutin, and multi‑peptide complexes within its proprietary K8‑Rejuvenate™ system. These ingredients target cellular energy, barrier repair, pigmentation, and structural support.

Q: How does JiYu ensure product quality? A: JiYu manufactures in South Korea under an ODM with certifications including CGMP, ISO 9001, ISO 14001, and ISO 22716. Products are imported directly from Korean facilities without domestic reformulation, preserving formulation fidelity and consistent manufacturing standards.

Q: Where can JiYu products be purchased? A: JiYu sells through its Shopify storefront (jiyuskin.com), Amazon, and TikTok Shop. The brand plans retail distribution expansion and has announced intentions to enter the South Korean market.

Q: Are topical NAD+ formulations effective? A: Topical NAD+ and its precursors aim to influence cellular repair and energy pathways, but effectiveness depends on molecular stability and delivery to target cells. Sophisticated delivery systems—encapsulation, liposomes—can enhance bioavailability. Clinical data are essential to substantiate efficacy for specific formulations.

Q: Why is clinical research important for longevity skincare? A: Longevity claims imply modulation of biological processes. Clinical research validates whether a product produces measurable benefits, supports precise marketing claims, and builds credibility with professionals and consumers. JiYu has allocated capital toward independent clinical studies to undergird its positioning.

Q: How should consumers incorporate longevity products into their routines? A: Introduce potent actives gradually, patch‑test new products, and consider professional guidance if combining multiple strong actives. Longevity outcomes depend on consistent use over weeks or months; products designed as part of a system often perform best when used as directed within a routine that includes photoprotection and barrier support.

Q: What are the risks for brands that position themselves around longevity? A: Risks include regulatory scrutiny over biologically framed claims, consumer skepticism without robust evidence, supply chain challenges during scale, and the technical difficulty of translating cellular science into topical efficacy. Investing in manufacturing quality, research, and transparent communication mitigates these risks.

Q: What should industry watchers pay attention to next? A: Watch JiYu’s clinical study releases, reception of the five planned 2026 product launches, retail distribution agreements, and the brand’s performance in the Korean market. These milestones will indicate whether longevity positioning paired with Korean formulation can scale beyond niche audiences to mainstream beauty consumers.

— End of article —